Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy

Juan F. Gallegos-Orozco; Kristina T. Werner; Marianne Rosati; Thomas J. Byrne; Vijayan Balan; Hugo E. Vargas; Jorge Rakela

doi:10.1111/j.1572-0241.2008.01982_18.x

Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy

Juan F. Gallegos-Orozco, Kristina T. Werner, Marianne Rosati, Thomas J. Byrne, Vijayan Balan, Hugo E. Vargas, Jorge Rakela

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2161-2162
Number of pages	2
Journal	American Journal of Gastroenterology
Volume	103
Issue number	8
DOIs	https://doi.org/10.1111/j.1572-0241.2008.01982_18.x
State	Published - Aug 2008

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1111/j.1572-0241.2008.01982_18.x

Cite this

Gallegos-Orozco, J. F., Werner, K. T., Rosati, M., Byrne, T. J., Balan, V., Vargas, H. E., & Rakela, J. (2008). Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy. American Journal of Gastroenterology, 103(8), 2161-2162. https://doi.org/10.1111/j.1572-0241.2008.01982_18.x

Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy. / Gallegos-Orozco, Juan F.; Werner, Kristina T.; Rosati, Marianne et al.
In: American Journal of Gastroenterology, Vol. 103, No. 8, 08.2008, p. 2161-2162.

Research output: Contribution to journal › Letter › peer-review

Gallegos-Orozco, JF, Werner, KT, Rosati, M, Byrne, TJ, Balan, V, Vargas, HE & Rakela, J 2008, 'Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy', American Journal of Gastroenterology, vol. 103, no. 8, pp. 2161-2162. https://doi.org/10.1111/j.1572-0241.2008.01982_18.x

@article{c963e921f0a547f183ce58a5c9f20cb4,

title = "Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy",

author = "Gallegos-Orozco, {Juan F.} and Werner, {Kristina T.} and Marianne Rosati and Byrne, {Thomas J.} and Vijayan Balan and Vargas, {Hugo E.} and Jorge Rakela",

year = "2008",

month = aug,

doi = "10.1111/j.1572-0241.2008.01982_18.x",

language = "English (US)",

volume = "103",

pages = "2161--2162",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy

AU - Gallegos-Orozco, Juan F.

AU - Werner, Kristina T.

AU - Rosati, Marianne

AU - Byrne, Thomas J.

AU - Balan, Vijayan

AU - Vargas, Hugo E.

AU - Rakela, Jorge

PY - 2008/8

Y1 - 2008/8

UR - http://www.scopus.com/inward/record.url?scp=49349096354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49349096354&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2008.01982_18.x

DO - 10.1111/j.1572-0241.2008.01982_18.x

M3 - Letter

C2 - 18796126

AN - SCOPUS:49349096354

SN - 0002-9270

VL - 103

SP - 2161

EP - 2162

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

IS - 8

ER -

Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this